Veering off the well-trodden path? European Merger Control and the Pharmaceutical Indutry* We have recently celebrated the 25th anniversary of the EU Merger Regulation, which came into force on 21 September 1990. Since that date, we have seen an exponential growth in merger control notifications at the European level – at least up until the financial crisis that began in 2008. The good news is that, to the end of September 2015, there have been 247 notifications this year. We appear to be on track for approximately 330 notification in total for 2015. This almost reaches the level of notifications in 2008 (348) – albeit somewhat off the all time high of 2007 (402). But what does this mean to the pharmaceutical industry? It has been at the vanguard of the resurgence in M&A since
The EU Commission increases merger control enforcement in the pharmaceutical sector
This article has been nominated for the 2016 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards.
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.